| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VETMIC.2016.11.026 |
| P698 | PubMed publication ID | 27923501 |
| P50 | author | Tavis K Anderson | Q40933293 |
| Daniel R. Perez | Q42737998 | ||
| Rasna R. Walia | Q45949722 | ||
| Amy L Vincent | Q88292443 | ||
| P2093 | author name string | Nicola S Lewis | |
| Eugenio J Abente | |||
| Daniela Rajao | |||
| P2860 | cites work | Origins of the 2009 H1N1 influenza pandemic in swine in Mexico | Q26278055 |
| Optimal Use of Vaccines for Control of Influenza A Virus in Swine | Q26783503 | ||
| Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head | Q26783897 | ||
| Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011 | Q28387606 | ||
| Mapping the antigenic and genetic evolution of influenza virus | Q29617255 | ||
| Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic | Q29619055 | ||
| Strengthening the influenza vaccine virus selection and development process. Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014 | Q30203189 | ||
| Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans | Q30207889 | ||
| Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus. | Q30354025 | ||
| Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. | Q30357665 | ||
| Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. | Q30361887 | ||
| Introductions and evolution of human-origin seasonal influenza a viruses in multinational swine populations. | Q30363990 | ||
| Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection | Q36365301 | ||
| Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs. | Q36378581 | ||
| The impact of maternally derived immunity on influenza A virus transmission in neonatal pig populations | Q36501567 | ||
| Isolation of novel triple-reassortant swine H3N2 influenza viruses possessing the hemagglutinin and neuraminidase genes of a seasonal influenza virus in Vietnam in 2010. | Q37086834 | ||
| Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v | Q37123473 | ||
| The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus | Q37224897 | ||
| Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs | Q37356103 | ||
| Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses | Q37397023 | ||
| Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine | Q37713949 | ||
| A brief introduction to influenza A virus in swine. | Q38217786 | ||
| The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. | Q40481132 | ||
| Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. | Q40835064 | ||
| Characterization of co-circulating swine influenza A viruses in North America and the identification of a novel H1 genetic clade with antigenic significance | Q41378135 | ||
| Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution | Q42253862 | ||
| Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine | Q43591484 | ||
| Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs | Q45361895 | ||
| Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus | Q45412862 | ||
| Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus. | Q45728824 | ||
| The geometry of shape space: application to influenza. | Q50682158 | ||
| Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014. | Q50950154 | ||
| Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation | Q59062494 | ||
| Expansion of genotypic diversity and establishment of 2009 H1N1 pandemic-origin internal genes in pigs in China. | Q30364522 | ||
| Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs. | Q30365286 | ||
| Detection of Novel Reassortant Influenza A (H3N2) and H1N1 2009 Pandemic Viruses in Swine in Hanoi, Vietnam. | Q30368347 | ||
| European surveillance network for influenza in pigs: surveillance programs, diagnostic tools and Swine influenza virus subtypes identified in 14 European countries from 2010 to 2013. | Q30370161 | ||
| Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface. | Q30370471 | ||
| Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses. | Q30370987 | ||
| Global migration of influenza A viruses in swine | Q30373105 | ||
| Swine influenza viruses a North American perspective. | Q30373922 | ||
| Influenza A Viruses of Human Origin in Swine, Brazil | Q30377008 | ||
| Molecular Epidemiology and Evolution of Influenza Viruses Circulating within European Swine between 2009 and 2013 | Q30377049 | ||
| Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States | Q30378432 | ||
| Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets. | Q30384443 | ||
| The global antigenic diversity of swine influenza A viruses | Q30387317 | ||
| Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses | Q30395088 | ||
| Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus | Q30399540 | ||
| Long-term evolution and transmission dynamics of swine influenza A virus | Q30403142 | ||
| Evidence of reassortment of pandemic H1N1 influenza virus in swine in Argentina: are we facing the expansion of potential epicenters of influenza emergence? | Q30403779 | ||
| Reassortment events among swine influenza A viruses in China: implications for the origin of the 2009 influenza pandemic | Q30405286 | ||
| Global transmission of influenza viruses from humans to swine | Q30419138 | ||
| Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection | Q30423733 | ||
| Infection dynamics of pandemic 2009 H1N1 influenza virus in a two-site swine herd | Q30425569 | ||
| Antigenic variation of H1N1, H1N2 and H3N2 swine influenza viruses in Japan and Vietnam | Q30427522 | ||
| Review of influenza A virus in swine worldwide: a call for increased surveillance and research. | Q30429021 | ||
| Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs | Q33843120 | ||
| The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) | Q34249741 | ||
| Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine | Q34561944 | ||
| Isolation and genetic characterization of new reassortant H3N1 swine influenza virus from pigs in the midwestern United States | Q34647892 | ||
| Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine | Q34700580 | ||
| Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease | Q34976021 | ||
| Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007. | Q35531698 | ||
| Novel swine influenza virus subtype H3N1, United States | Q36029466 | ||
| Disquisitions of Original Antigenic Sin. I. Evidence in man | Q36268293 | ||
| Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease | Q36276647 | ||
| P921 | main subject | influenza A virus | Q834390 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 35-44 | |
| P577 | publication date | 2016-11-24 | |
| P1433 | published in | Veterinary Microbiology | Q15761011 |
| P1476 | title | Influenza A virus vaccines for swine | |
| P478 | volume | 206 |
| Q59352631 | Antigenic evolution of H3N2 influenza A viruses in swine in the United States from 2012 to 2016 |
| Q91828222 | Biotinylated Single-Domain Antibody-Based Blocking ELISA for Detection of Antibodies Against Swine Influenza Virus |
| Q48109162 | Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure. |
| Q103759905 | Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs |
| Q90280392 | DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs |
| Q59356365 | Detailed mapping of the linear B Cell epitopes of the hemagglutinin (HA) protein of swine influenza virus |
| Q89889376 | Detection of live attenuated influenza vaccine virus and evidence of reassortment in the U.S. swine population |
| Q92904552 | Double-attenuated influenza virus elicits broad protection against challenge viruses with different serotypes in swine |
| Q61818352 | Effect of strain-specific maternally-derived antibodies on influenza A virus infection dynamics in nursery pigs |
| Q90489301 | Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs |
| Q90395121 | Evolution and Pathogenicity of the H1 and H3 Subtypes of Swine Influenza Virus in Mice between 2016 and 2019 in China |
| Q30234558 | Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine |
| Q64091805 | Human-Origin Influenza A(H3N2) Reassortant Viruses in Swine, Southeast Mexico |
| Q64056986 | Influenza A virus shedding reduction observed at 12 weeks post-vaccination when newborn pigs are administered live-attenuated influenza virus vaccine |
| Q42700289 | Influenza Herd-Level Prevalence and Seasonality in Breed-to-Wean Pig Farms in the Midwestern United States |
| Q58698634 | Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs |
| Q47566276 | Live-attenuated influenza virus vaccine reduces virus shedding of newborn piglets in the presence of maternal antibody. |
| Q64276517 | Longitudinal field studies reveal early infection and persistence of influenza A virus in piglets despite the presence of maternally derived antibodies |
| Q54209314 | Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs. |
| Q91316567 | Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy |
| Q90397530 | Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2 |
| Q57091953 | Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections |
| Q96813580 | Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice |
| Q59349605 | Regional patterns of genetic diversity in swine influenza A viruses in the United States from 2010 to 2016 |
| Q92532361 | Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme |
| Q98474942 | Swine Influenza Virus: Current Status and Challenge |
| Q64238019 | T and B Cell Immune Responses to Influenza Viruses in Pigs |
| Q64106943 | Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus |
| Q91447866 | Virological and epidemiological patterns of swine influenza A virus infections in France: Cumulative data from the RESAVIP surveillance network, 2011-2018 |
| Q92507646 | octoFLU: Automated Classification for the Evolutionary Origin of Influenza A Virus Gene Sequences Detected in U.S. Swine |
Search more.